Dr. Reddy’s announces positive topline results from phase 2b study of PPC-06 in moderate to severe plaque psoriasis
In the study, PPC-06 met both co-primary endpoints i.e. PASI-75 and IGA scores of 0 or 1 with at least a 2-point reduction from baseline, after 24 weeks